• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Expression and characterization of soluble epitope-defined major histocompatibility complex (MHC) from stable eukaryotic cell lines.可溶性表位定义的主要组织相容性复合体 (MHC) 在稳定真核细胞系中的表达和特性。
J Immunol Methods. 2019 Jan;464:22-30. doi: 10.1016/j.jim.2018.10.006. Epub 2018 Oct 19.
2
Dimerization of soluble disulfide trap single-chain major histocompatibility complex class I molecules dependent on peptide binding affinity.可溶性二硫键陷阱单链主要组织相容性复合体 I 分子的二聚化依赖于肽结合亲和力。
Antioxid Redox Signal. 2011 Aug 1;15(3):635-44. doi: 10.1089/ars.2010.3691. Epub 2011 Apr 8.
3
Construction of bioactive chimeric MHC class I tetramer by expression and purification of human-murine chimeric MHC heavy chain and beta(2)m as a fusion protein in Escherichia coli.通过在大肠杆菌中表达和纯化人-鼠嵌合MHC重链和β2微球蛋白融合蛋白构建生物活性嵌合MHC I类四聚体。
Protein Expr Purif. 2006 Dec;50(2):171-8. doi: 10.1016/j.pep.2006.08.001. Epub 2006 Aug 11.
4
MHC-Peptide Tetramers to Visualize Antigen-Specific T Cells.用于可视化抗原特异性T细胞的MHC-肽四聚体
Curr Protoc Immunol. 2016 Nov 1;115:17.3.1-17.3.44. doi: 10.1002/cpim.14.
5
A mutant human beta2-microglobulin can be used to generate diverse multimeric class I peptide complexes as specific probes for T cell receptors.一种突变型人β2-微球蛋白可用于生成多种多聚体I类肽复合物,作为T细胞受体的特异性探针。
J Immunol Methods. 1998 May 1;214(1-2):41-50. doi: 10.1016/s0022-1759(98)00035-0.
6
Low binding capacity of murine tetramers mutated at residue 227 does not preclude the ability to efficiently activate CD8+ T lymphocytes.在第227位残基处发生突变的鼠源四聚体结合能力较低,但这并不妨碍其有效激活CD8+ T淋巴细胞的能力。
Immunol Lett. 2005 May 15;98(2):208-15. doi: 10.1016/j.imlet.2004.11.016. Epub 2004 Dec 10.
7
An enhanced and scalable process for the purification of SIV Gag-specific MHC tetramer.一种用于纯化SIV Gag特异性MHC四聚体的增强型可扩展方法。
Protein Expr Purif. 2001 Nov;23(2):270-81. doi: 10.1006/prep.2001.1507.
8
Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes.缺乏H2 I类表达的人MHC I类转基因小鼠有助于鉴定和表征新的HLA I类限制性病毒T细胞表位。
J Immunol. 2002 Nov 15;169(10):5571-80. doi: 10.4049/jimmunol.169.10.5571.
9
A single-chain fusion molecule consisting of peptide, major histocompatibility gene complex class I heavy chain and beta2-microglobulin can fold partially correctly, but binds peptide inefficiently.一种由肽、主要组织相容性基因复合体I类重链和β2-微球蛋白组成的单链融合分子能够部分正确折叠,但结合肽的效率低下。
Scand J Immunol. 1999 Oct;50(4):355-62. doi: 10.1046/j.1365-3083.1999.00601.x.
10
Random peptide libraries. A tool for analyzing peptide specificity of major histocompatibility complex class I molecules.随机肽库。一种分析主要组织相容性复合体I类分子肽特异性的工具。
Methods Mol Biol. 2001;156:187-99. doi: 10.1385/1-59259-062-4:187.

引用本文的文献

1
Modeling antibody drug conjugate potential using a granzyme B antibody fusion protein.利用颗粒酶 B 抗体融合蛋白对抗体药物偶联物的潜力进行建模。
BMC Biol. 2024 Mar 14;22(1):66. doi: 10.1186/s12915-024-01860-x.
2
MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection.MediMer:一种多功能 DIY 肽受体 MHC Ⅰ类多聚体平台,用于肿瘤新抗原特异性 T 细胞检测。
Front Immunol. 2024 Jan 4;14:1294565. doi: 10.3389/fimmu.2023.1294565. eCollection 2023.
3
Production of soluble pMHC-I molecules in mammalian cells using the molecular chaperone TAPBPR.利用分子伴侣TAPBPR在哺乳动物细胞中生产可溶性pMHC-I分子。
Protein Eng Des Sel. 2019 Dec 31;32(12):525-532. doi: 10.1093/protein/gzaa015.
4
MHC-I peptide binding activity assessed by exchange after cleavage of peptide covalently linked to β2-microglobulin.通过与β2-微球蛋白共价连接的肽裂解后交换评估 MHC-I 肽结合活性。
Anal Biochem. 2019 Nov 1;584:113328. doi: 10.1016/j.ab.2019.05.017. Epub 2019 Jun 13.

本文引用的文献

1
CEACAM1 promotes CD8 T cell responses and improves control of a chronic viral infection.CEACAM1 促进 CD8 T 细胞应答,改善慢性病毒感染的控制。
Nat Commun. 2018 Jul 2;9(1):2561. doi: 10.1038/s41467-018-04832-2.
2
MHC class I presented antigens from malignancies: A perspective on analytical characterization & immunogenicity.MHC Ⅰ类呈递恶性肿瘤抗原:分析特征与免疫原性的视角。
J Proteomics. 2019 Jan 16;191:48-57. doi: 10.1016/j.jprot.2018.04.021. Epub 2018 Apr 24.
3
TCR tuning of T cell subsets.T 细胞亚群的 TCR 调节。
Immunol Rev. 2018 May;283(1):129-137. doi: 10.1111/imr.12646.
4
Cell Biology of T Cell Receptor Expression and Regulation.T 细胞受体表达和调节的细胞生物学。
Annu Rev Immunol. 2018 Apr 26;36:103-125. doi: 10.1146/annurev-immunol-042617-053429. Epub 2017 Dec 20.
5
Towards personalized, tumour-specific, therapeutic vaccines for cancer.为癌症的个体化、肿瘤特异性治疗性疫苗而努力。
Nat Rev Immunol. 2018 Mar;18(3):168-182. doi: 10.1038/nri.2017.131. Epub 2017 Dec 11.
6
The emerging role of systems biology for engineering protein production in CHO cells.系统生物学在 CHO 细胞中工程蛋白生产中的新兴作用。
Curr Opin Biotechnol. 2018 Jun;51:64-69. doi: 10.1016/j.copbio.2017.11.015. Epub 2017 Dec 7.
7
Gene Therapy with the Sleeping Beauty Transposon System.基因治疗与睡美人转座子系统。
Trends Genet. 2017 Nov;33(11):852-870. doi: 10.1016/j.tig.2017.08.008. Epub 2017 Sep 27.
8
Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation.主要组织相容性复合体(MHC)I类和MHC II类蛋白:抗原呈递中的构象可塑性
Front Immunol. 2017 Mar 17;8:292. doi: 10.3389/fimmu.2017.00292. eCollection 2017.
9
TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targets.TCR样抗体药物偶联物介导对低肽/HLA靶点肿瘤细胞的杀伤作用。
MAbs. 2017 May/Jun;9(4):603-614. doi: 10.1080/19420862.2017.1302630.
10
MHC-Peptide Tetramers to Visualize Antigen-Specific T Cells.用于可视化抗原特异性T细胞的MHC-肽四聚体
Curr Protoc Immunol. 2016 Nov 1;115:17.3.1-17.3.44. doi: 10.1002/cpim.14.

可溶性表位定义的主要组织相容性复合体 (MHC) 在稳定真核细胞系中的表达和特性。

Expression and characterization of soluble epitope-defined major histocompatibility complex (MHC) from stable eukaryotic cell lines.

机构信息

Department of Immunotherapeutics and Biotechnology, School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX 79601, United States.

Department of Immunotherapeutics and Biotechnology, School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX 79601, United States.

出版信息

J Immunol Methods. 2019 Jan;464:22-30. doi: 10.1016/j.jim.2018.10.006. Epub 2018 Oct 19.

DOI:10.1016/j.jim.2018.10.006
PMID:30347189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6322931/
Abstract

MHC class I-specific reagents such as fluorescently-labeled multimers (e.g., tetramers) have greatly advanced the understanding of CD8+ T cells under normal and diseased states. However, recombinant MHC class I components (comprising MHC class I heavy chain and β2 microglobulin) are usually produced in bacteria following a lengthy purification protocol that requires additional non-covalent folding steps with exogenous peptide for complete molecular assembly. We have provided an alternative and rapid approach to generating soluble and fully-folded MHC class I molecules in eukaryotic cell lines (such as CHO cells) using a Sleeping Beauty transposon system. Importantly, this method culminates in generating stable cell lines that reliably secrete epitope-defined MHC class I molecules into the tissue media for convenient purification and eventual biotinylation/multimerization. Additionally, MHC class I components are covalently linked, providing the opportunity to produce a diverse set of CD8+ T cell-specific reagents bearing peptides with various affinities to MHC class I.

摘要

MHC I 类特异性试剂,如荧光标记的多聚体(例如四聚体),极大地促进了对正常和患病状态下 CD8+T 细胞的理解。然而,重组 MHC I 类成分(包括 MHC I 类重链和β2 微球蛋白)通常在细菌中产生,需要经过冗长的纯化方案,其中需要与外源肽进行额外的非共价折叠步骤,以完成完整的分子组装。我们提供了一种替代方法,可在真核细胞系(如 CHO 细胞)中使用 Sleeping Beauty 转座子系统生成可溶性和完全折叠的 MHC I 类分子。重要的是,该方法最终生成了稳定的细胞系,可将表位定义的 MHC I 类分子可靠地分泌到组织培养基中,便于进行纯化和最终的生物素化/多聚化。此外,MHC I 类成分通过共价键连接,为生成具有各种 MHC I 类亲和力的肽的多样化 CD8+T 细胞特异性试剂提供了机会。